Evidence map›Paper›PMID 41426294›Full record

ArticleKDD : proceedings. International Conference on Knowledge Discovery & Data Mining2025

Identifying Combinatorial Regulatory Genes for Cell Fate Decision via Reparameterizable Subset Explanations.

Junhao Liu, Pengpeng Zhang, Martin Renqiang Min, Jing Zhang

Abstract read
In one paragraph

Article in KDD : proceedings. International Conference on Knowledge Discovery & Data Mining, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Junhao LiuUniversity of California, Irvine, Department of Computer Science, Irvine, California, USA.
Pengpeng ZhangUniversity of California, Irvine, Department of Computer Science, Irvine, California, USA.
Martin Renqiang MinNEC Laboratories America, Department of Machine Learning, Princeton, New Jersey, USA.
Jing ZhangUniversity of California, Irvine, Department of Computer Science, Irvine, California, USA.

Funding

Interpretable Deep Learning Methods to Investigate Genetics and Epigenetics of Alzheimer's Disease at a Single-Cell ResolutionR01NS128523 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI JING ZHANG · 2022 to 2026
$3.2M
Decoding the Noncoding Regulatory Genome with Super-resolution via Single-cell Multiomics IntegrationR01HG012572 · NHGRI · UNIVERSITY OF CALIFORNIA-IRVINE · PI JING ZHANG · 2022 to 2026
$2.0M
NHGRI NIH HHS R01 HG012572NINDS NIH HHS R01 NS128523
6 · The paper itself

Abstract

Cell fate decisions are highly coordinated processes governed by complex interactions among numerous regulatory genes, while disruptions in these mechanisms can lead to developmental abnormalities and disease. Traditional methods often fail to capture such combinatorial interactions, limiting their ability to fully model cell fate dynamics. Here, we introduce MetaVelo, a global feature explanation framework for identifying key regulatory gene sets influencing cell fate transitions. MetaVelo models these transitions as a black-box function and employs a differentiable neural ordinary differential equation (ODE) surrogate to enable efficient optimization. By reparameterizing the problem as a controllable data generation process, MetaVelo overcomes the challenges posed by the non-differentiable nature of cell fate dynamics. Benchmarking across diverse stand-alone and longitudinal single-cell RNA-seq datasets and three black-box cell fate models demonstrates its superiority over 12 baseline methods in predicting developmental trajectories and identifying combinatorial regulatory gene sets. MetaVelo further distinguishes independent from synergistic regulatory genes, offering novel insights into the gene interactions governing cell fate. With the growing availability of high-resolution single-cell data, MetaVelo provides a scalable and effective framework for advancing developmental biology and therapeutic applications.

Indexed as

AI for ScienceRegulatory Gene IdentificationSingle-Cell Data

Identifiers

PMID41426294
PMCPMC12718083

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.